View Older Stories View More Recent Stories

Jan 16, 2020 09:30AM Pre-Open Stock Movers 01/16: (MNI) (SIG) (XPO) Higher (BK) (TSLA) (PPG) Lower (more...)
Jan 16, 2020 09:26AM UPDATE: Cantor Fitzgerald Starts Compugen (CGEN) at Overweight
Jan 16, 2020 06:59AM PolarityTE (PTE) Case Studies Reinforce Long Term Opportunity - Cantor Fitzgerald
Jan 14, 2020 04:01PM Aptinyx Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option
Jan 14, 2020 04:01PM Aptinyx Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option
Jan 14, 2020 12:26PM Cantor Fitzgerald Reiterates Overweight Rating on PolarityTE (PTE) Following Meetings
Jan 14, 2020 08:44AM HealthEquity, Inc (HQY) PT Lowered to $90 at Cantor Fitzgerald
Jan 14, 2020 08:11AM Mudrick Capital Acquisition Corporation To Combine With Hycroft Mining Corporation
Jan 14, 2020 07:03AM Mereo BioPharma Group (MERO) Reports Additional Positive Data from Phase 2b ASTEROID Study of Setrusumab in Adults with Osteogenesis Imperfecta; Provides Update on Regulatory Progress
Jan 14, 2020 07:00AM Mereo BioPharma Announces Additional Positive Data from Phase 2b ASTEROID Study of Setrusumab in Adults with Osteogenesis Imperfecta and Provides Update on Regulatory Progress
Jan 14, 2020 07:00AM Mereo BioPharma Announces Additional Positive Data from Phase 2b ASTEROID Study of Setrusumab in Adults with Osteogenesis Imperfecta and Provides Update on Regulatory Progress
Jan 14, 2020 06:02AM Form 13F-HR CANTOR FITZGERALD INVEST For: Dec 31
Jan 13, 2020 12:10PM Apellis Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares
Jan 13, 2020 12:10PM Apellis Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares
Jan 13, 2020 11:50AM Rumors Perrigo Co. (PRGO) Acquiring Akorn (AKRX) 'Likely Not True' - Cantor Fitzgerald
Jan 13, 2020 07:23AM Two Pieces of Good News for Amarin (AMRN) - Cantor Fitzgerald
Jan 13, 2020 07:00AM Mereo BioPharma and Oncologie Enter into Global Licensing Agreement for Navicixizumab
Jan 13, 2020 07:00AM Mereo BioPharma and Oncologie Enter into Global Licensing Agreement for Navicixizumab
Jan 13, 2020 07:00AM Mereo BioPharma and Oncologie Enter into Global Licensing Agreement for Navicixizumab
Jan 10, 2020 09:45AM Dermira (DERM) Trades Above Deal Price on Speculation of Higher Bid
Jan 10, 2020 09:01AM Aptinyx (APTX) Prices 10.17M Share Common Stock Offering at $3/shh
Jan 10, 2020 09:00AM Aptinyx Announces Pricing of Public Offering of Common Stock
Jan 10, 2020 09:00AM Aptinyx Announces Pricing of Public Offering of Common Stock
Jan 10, 2020 08:49AM Intuitive Surgical (ISRG) PT Raised to 'Street High' $690 at Cantor Fitzgerald on Strong Q4
Jan 10, 2020 08:01AM Cidara Therapeutics (CDTX) Announces Proposed $30M Rights Offering
Jan 10, 2020 08:00AM Cidara Therapeutics Announces Proposed Rights Offering
Jan 9, 2020 05:55AM Apellis Pharmaceuticals (APLS) Prices 9.5M Share Offering at $37/Sh
Jan 8, 2020 09:30PM Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Jan 8, 2020 09:30PM Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Jan 8, 2020 04:05PM Cantor Fitzgerald Starts Phreesia Inc. (PHR) at Overweight
Jan 8, 2020 04:04PM Cantor Fitzgerald Starts BiomX (PHGE) at Overweight
Jan 8, 2020 11:56AM Cantor Fitzgerald Defends Amarin (AMRN), Says Headlines 'Noise'
Jan 8, 2020 06:50AM Amarin Corporation (AMRN) Updated Guidance In Line, Cantor Fitzgerald Reiterates Outperform
Jan 8, 2020 05:54AM Intra-Cellular Therapies (ITCI) Prices 10M Share Common Offering at $29.50/Sh
Jan 7, 2020 09:47PM Intra-Cellular Therapies Prices Public Offering of Common Stock
Jan 7, 2020 01:37PM Hecla Mining (HL) PT Raised to $4 at Cantor Fitzgerald, After Reporting 22% Higher Silver and 4% Higher Gold Production
Jan 7, 2020 08:08AM Apellis Pharmaceuticals (APLS) Data Exceeded Expectations, Expect Shares to Fly - Cantor Fitzgerald
Jan 7, 2020 07:42AM Amarin Corporation (AMRN) Expenses May Drive Expenses Higher but Vascepa Peak Sales Remains the Key for Investors - Cantor Fitzgerald
Jan 3, 2020 06:42AM Incyte (INCY) PT Lowered to $65 at Cantor Fitzgerald
Jan 2, 2020 10:34AM Health Canada Approval Underscores Global Market Opportunity for Amarin's (AMRN) Vascepa - Cantor Fitzgerald
Jan 2, 2020 07:48AM Wall Street starts 2020 with new records on China stimulus, trade hopes
Jan 2, 2020 05:36AM Aurora Cannabis (ACB:CN) (ACB) PT Lowered to Cdn$5 at Cantor Fitzgerald
Dec 31, 2019 04:53PM Energy Fuels Renews Its ATM Program
Dec 31, 2019 10:27AM Evolent Health (EVH) Closed Passport Deal and Improved Balance Sheet - Cantor Fitzgerald
Dec 30, 2019 03:00PM Axsome Therapeutics (AXSM) PT Raised to $125 at Cantor Fitzgerald
Dec 26, 2019 09:25AM Cantor Fitzgerald Downgrades Spectrum Pharmaceuticals (SPPI) to Neutral
Dec 23, 2019 04:19PM Axsome Therapeutics Announces Closing of $200 Million Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Dec 23, 2019 04:19PM Axsome Therapeutics Announces Closing of $200 Million Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Dec 23, 2019 04:10PM Cantor Fitzgerald Starts Stemline Therapeutics (STML) at Overweight
Dec 23, 2019 07:18AM Cantor Fitzgerald Starts Taiwan Liposome Co. Ltd. (TLC) at Overweight
View More Recent Stories View Older Stories